Chronic nandrolone administration induces dysfunction of the reward pathway in rats

Steroids

Volumn 79, Issue , 2014, Pages 7-13

  Zotti, Margherita ^a   Tucci, Paolo ^a   Colaianna, Marilena ^a,b   Morgese, Maria Grazia ^a   Mhillaj, Emanuela ^a,c   Schiavone, Stefania ^b   Scaccianoce, Sergio ^c   Cuomo, Vincenzo ^c   Trabace, Luigia ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amygdala; Dopamine; Noradrenaline; Nucleus accumbens; Serotonin

Indexed keywords

DOPAMINE; NANDROLONE DECANOATE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; EMOTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAZE TEST; NONHUMAN; NUCLEUS ACCUMBENS; RAT; REWARD; SOCIAL INTERACTION; SWEETNESS; TASTE PREFERENCE;

ANIMALIA; RATTUS;

ANABOLIC AGENTS; ANHEDONIA; ANIMALS; BRAIN; BRAIN CHEMISTRY; DOPAMINE; FOOD PREFERENCES; INJECTIONS, SUBCUTANEOUS; MALE; MAZE LEARNING; NANDROLONE; NOREPINEPHRINE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; REWARD; SEROTONIN; SOCIAL BEHAVIOR; SUCROSE; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 84887582623     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.10.005     Document Type: Article

References (47)

1. A.M. Kindlundh, D.G. Isacson, L. Berglund, and F. Nyberg Factors associated with adolescent use of doping agents: anabolic-androgenic steroids Addiction 94 1999 543 553 (Pubitemid 29179125)
2. B.E. Denham The anabolic steroid control act of 2004: a study in the political economy of drug policy J Health Soc Policy 22 2006 51 78 (Pubitemid 46361046)
3. C.E. Yesalis, and M.S. Bahrke Anabolic-androgenic steroids Curr Issues Sports Med 19 1995 326 340
4. J.G. Oberlander, and L.P. Henderson The Sturm und Drang of anabolic steroid use: angst, anxiety, and aggression Trends Neurosci 35 2012 382 392
5. B.A. Costine, J.G. Oberlander, M.C. Davis, C.A. Penatti, D.M. Porter, and R.N. Leaton Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse Psychoneuroendocrinology 35 2010 1473 1485
6. S. Kailanto, A. Kankaanpaa, and T. Seppala Subchronic steroid administration induces long lasting changes in neurochemical and behavioral response to cocaine in rats Steroids 76 2011 1310 1316
7. F. Nyberg, and M. Hallberg Interactions between opioids and anabolic androgenic steroids: implications for the development of addictive behavior Int Rev Neurobiol 102 2012 189 206
8. F. Matrisciano, A.M. Modafferi, G.I. Togna, Y. Barone, G. Pinna, and F. Nicoletti Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior Neuropharmacology 58 2010 1078 1084
9. C. Birgner, A.M. Kindlundh-Hogberg, F. Nyberg, and L. Bergstrom Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge Neurosci Lett 412 2007 168 172 (Pubitemid 46074357)
10. S. Chiavegatto, I.M. Quadros, G. Ambar, and K.A. Miczek Individual vulnerability to escalated aggressive behavior by a low dose of alcohol: decreased serotonin receptor mRNA in the prefrontal cortex of male mice Genes Brain Behav 9 2010 110 119
11. L.A. Ricci, T.R. Morrison, and R.H. Melloni Jr. Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters Horm Behav 62 2012 569 578
12. T. Tamaki, T. Shiraishi, H. Takeda, T. Matsumiya, R.R. Roy, and V.R. Edgerton Nandrolone decanoate enhances hypothalamic biogenic amines in rats Med Sci Sports Exerc 35 2003 32 38 (Pubitemid 36084137)
13. P. Tucci, M.G. Morgese, M. Colaianna, M. Zotti, S. Schiavone, and V. Cuomo Neurochemical consequence of steroid abuse: stanozolol-induced monoaminergic changes Steroids 77 2012 269 275
14. Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories, Substances Identified in Anabolic Agents Drug Class. < http://www.wada-ama.org >; World Anti-Doping Agency, 2011.
15. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 1985 149 167 (Pubitemid 16239568)
16. File SE, Lippa AS, Beer B, Lippa MT. Animal tests of anxiety. In: Jacqueline N. Crawley, et al., editors. Current protocols in neuroscience/editorial board; 2004; Chapter 8: Unit 8 3.
17. T. Romeas, M.C. Morissette, O. Mnie-Filali, G. Pineyro, and S.M. Boye Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression Psychopharmacology 205 2009 293 303
18. M.E. Breuer, M.Y. McGinnis, A.R. Lumia, and B.P. Possidente Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation Horm Behav 40 2001 409 418 (Pubitemid 33063569)
19. L.M. Monteggia, B. Luikart, M. Barrot, D. Theobold, I. Malkovska, and S. Nef Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors Biol Psychiatry 61 2007 187 197 (Pubitemid 46072778)
20. R.J. Niesink, and J.M. van Ree Short-term isolation increases social interactions of male rats: a parametric analysis Physiol Behav 29 1982 819 825 (Pubitemid 13183603)
21. S.E. File, A. Zharkovsky, and K. Gulati Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat Neuropharmacology 30 1991 183 190
22. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1998 Elsevier Academic Press
23. M. Francavilla, M. Colaianna, M. Zotti, M.G. Morgese, P. Trotta, and P. Tucci Extraction, characterization and in vivo neuromodulatory activity of phytosterols from microalga Dunaliella tertiolecta Curr Med Chem 19 2012 3058 3067
24. S.E. Lukas Current perspectives on anabolic-androgenic steroid abuse Trends Pharmacol Sci 14 1993 61 68 (Pubitemid 23049342)
25. A.J. Gruber, and H.G. Pope Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women Psychother Psychosom 69 2000 19 26
26. T.A. Pagonis, N.V. Angelopoulos, G.N. Koukoulis, and C.S. Hadjichristodoulou Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse Eur Psychiatry 21 2006 551 562 (Pubitemid 44855525)
27. M.S. Bahrke, C.E. Yesalis 3rd, and J.E. Wright Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review Sports Med 10 1990 303 337 (Pubitemid 20322402)
28. A.S. Clark, and A.S. Fast Comparison of the effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the sexual behavior of castrated male rats Behav Neurosci 110 1996 1478 1486 (Pubitemid 27009209)
29. S. Kurling, A. Kankaanpaa, S. Ellermaa, T. Karila, and T. Seppala The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats Brain Res 1044 2005 67 75 (Pubitemid 40616053)
30. First M, Frances A, Pincus H. Dsm-IV-Tr(r) handbook of differential diagnosis, 2002.
31. N. Kokras, K. Antoniou, C. Dalla, S. Bekris, M. Xagoraris, and D.H. Ovestreet Sex-related differential response to clomipramine treatment in a rat model of depression J Psychopharmacol 23 2009 945 956
32. W. Schultz, P. Dayan, and P.R. Montague A neural substrate of prediction and reward Science 275 1997 1593 1599 (Pubitemid 27120526)
33. D.C. Roberts, M.E. Corcoran, and H.C. Fibiger On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine Pharmacol Biochem Behav 6 1977 615 620 (Pubitemid 8147152)
34. G.F. Koob, and M. Le Moal Plasticity of reward neurocircuitry and the 'dark side' of drug addiction Nature Neurosci 8 2005 1442 1444 (Pubitemid 41573653)
35. G. Yadid, D.H. Overstreet, and A. Zangen Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression Brain Res 896 2001 43 47 (Pubitemid 32244145)
36. V. Bassareo, and G. Di Chiara Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state Eur J Neurosci 11 1999 4389 4397 (Pubitemid 30009271)
37. K.M. Tye, J.J. Mirzabekov, M.R. Warden, E.A. Ferenczi, H.C. Tsai, and J. Finkelstein Dopamine neurons modulate neural encoding and expression of depression-related behaviour Nature 493 2013 537 541
38. D.E. Comings, and K. Blum Reward deficiency syndrome: genetic aspects of behavioral disorders Prog Brain Res 126 2000 325 341 (Pubitemid 35461297)
39. M.E. Yacoubi, D. Popa, B. Martin, L. Zimmer, M. Hamon, and J. Adrien Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice Int J Neuropsychopharmacol 2011 1 12
40. A.M. Kindlundh, J. Lindblom, and F. Nyberg Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain Brain Res 979 2003 37 42 (Pubitemid 36792153)
41. S. Kurling, A. Kankaanpaa, and T. Seppala Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats Behav Brain Res 189 2008 191 201
42. B.E. Leonard The role of noradrenaline in depression: a review J Psychopharmacol 11 1997 S39 S47
43. B.J. Cole, M. Hillmann, D. Seidelmann, M. Klewer, and G.H. Jones Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat Psychopharmacology 121 1995 118 126
44. S.E. File, and J.R. Hyde Can social interaction be used to measure anxiety? Br J Pharmacol 62 1978 19 24 (Pubitemid 8251893)
45. A.L. Johnston, and S.E. File Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites Pharmacol Biochem Behav 32 1989 151 156 (Pubitemid 19125930)
46. M.J. Kim, R.A. Loucks, A.L. Palmer, A.C. Brown, K.M. Solomon, and A.N. Marchante The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety Behav Brain Res 223 2011 403 410
47. G.L. Quirarte, R. Galvez, B. Roozendaal, and J.L. McGaugh Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs Brain Res 808 1998 134 140 (Pubitemid 29009546)